Medvolt

Medvolt is an AI-driven drug discovery and development company whose mission is to revolutionize early-stage pharmaceutical research by democratizing access to cutting-edge generative AI and advanced physics-based simulation technology. Through its highly modular, data-driven in silico platform, Medvolt enhances existing R&D workflows, reduces costs, and significantly boosts success rates — ultimately serving patients by bringing new treatments to market faster and more affordably. The company serves a broad range of clients including pharma and biotech companies, research institutions, and translational research teams globally.

At the core of Medvolt's offering is MedGraph, an AI-accelerated in silico platform that empowers the generation of novel insights through efficient, resource-optimized pipelines. These insights are designed to translate directly into tangible experimental results. The platform is built on interpretable, data-centric AI models trained on carefully curated domain data, with a real-time visualization interface spanning the full drug discovery pipeline. Medvolt's multidisciplinary team brings expertise across biophysics, chemistry, biology, big data, AI/ML, high-performance computing, and cloud engineering, and all modules are validated through rigorous experimental evidence.

Core Technology Pillars

• Data Ocean: Medvolt aggregates and curates vast multi-modal biomedical and biochemical datasets using human-in-the-loop AI. This continuously updated, high-integrity data lake powers translational research and accelerates drug discovery with precision and reliability.
• AI-Driven Drug Discovery Engine: Medvolt's AI engine integrates generative models, natural language processing (NLP), transfer learning, and reinforcement learning to streamline in silico drug discovery. By combining proprietary datasets with deep domain expertise, the platform overcomes traditional R&D bottlenecks to deliver faster, smarter results.
• Modular and Scalable Cloud-Native Platform: Built for flexibility, the platform enables scalable, secure, and user-friendly access to AI-powered simulations. Clients can build custom workflows, launch high-performance computing (HPC) experiments, and collaborate seamlessly from an intuitive interface.
• Knowledge Graph Intelligence: Medvolt transforms unstructured biomedical data into a structured, ontology-driven knowledge graph with deep reasoning capabilities. This forms the backbone of its AI models, combining large language models (LLMs) with curated domain knowledge to unlock actionable biomedical insights.

MedGraph Platform Modules

• MedGraph – Rubie: A distinctive and versatile drug repurposing platform offering two distinct approaches — the repositioning of existing drugs and the identification of therapeutic targets for those drugs.
• MedGraph – Topaaz: A rapid, enterprise-class platform combining advanced AI and physics-based molecular modeling techniques to expedite the development of novel chemical entities while ensuring a robust toxicology profile.
• MedGraph EDGE: A module that swiftly and accurately extracts insights from an extensive array of data sources to provide compelling evidence for new predictions in drug discovery.
• MedGraph – Oopal – FEP: Leverages proprietary physics-based methods for precise free energy perturbation (FEP) simulations, accelerating accurate drug discovery and lead optimization.

Solutions Offered

• Small Molecule Drug Discovery: Medvolt's AI-driven in silico platform accelerates small molecule drug discovery, generating novel compounds faster and more cost-effectively with optimal pharmacological profiles.
• Large Molecule Drug Discovery: Using a full-stack AI-powered platform, Medvolt explores uncharted chemical space to identify potentially safe large molecules as therapies for a wide range of diseases.
• Peptide Therapeutics: Medvolt identifies the best binding, synthesizable, and selective peptides with optimal physicochemical and pharmacological properties by combining cutting-edge in silico and physics-based modeling methods.
• Knowledge Curation Services: Medvolt offers dedicated knowledge curation services to unlock the power of curated data for groundbreaking discoveries in drug development and precision medicine.

Key Platform Advantages

• Cuts pre-clinical discovery time by 3x, reduces costs by 15x, and lowers failure risk by 25% compared to traditional approaches.
• Provides access to proprietary, gold-standard, high-throughput datasets enriched by AI and NLP solutions for speed, precision, and scalability.
• Designed to be affordable, modular, and flexible to cater to the diverse needs of a broad range of clients — from startups to large enterprises.
• All AI models and modules are enhanced and validated through rigorous experimental validation, ensuring scientific credibility.

Partners, Recognition, and Ecosystem

• Medvolt is supported by and affiliated with leading organizations including AWS Startups, NVIDIA Inception, Microsoft for Startups, MeitY Startup Hub, DPIIT-SISFS, C-CAMP, Startup India, Make in India, and Science and Technology Park, Pune, among others.
• Research and industry partners include Savitribai Phule Pune University, ACTREC, Jaivika Healthcare, OmicsBank, Optimum Data Analytics, and Resync Bio.
• Co-Founder and CEO Dr. Madhura Vipra was invited as a Special Guest by DBT BIRAC under the Ministry of Science and Technology, Government of India, at the 77th Republic Day Ceremony, and represented Medvolt as a panelist at the India AI Impact Summit 2026, discussing AI-enabled biomanufacturing and next-generation medicines.
• Medvolt participated in the India AI Impact Summit 2026 Startup Expo at Bharat Mandapam, New Delhi, showcasing MedGraph's capabilities in predictive discovery, protein engineering, and AI-guided optimization.

Led by Co-Founder and CEO Dr. Madhura Vipra, who brings extensive experience in translational biomedical research, NLP, and ML-powered knowledge discovery, and Co-Founder and CTO Ritvik Vipra, an IIT Roorkee graduate with deep expertise in machine learning, deep learning, and enterprise AI product development, Medvolt is positioned as a comprehensive, technology-driven partner for organizations seeking to accelerate pharmaceutical R&D across the early-stage value chain.